Halea A. Corcoran

Pharmacological Characterization of MK-0974 [N-[(3 R,6 S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1 H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

Christopher Salvatore, James C. Hershey, Halea A. Corcoran et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 145 citations

Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay

James C. Hershey, Halea A. Corcoran, Elizabeth Baskin et al. · Regulatory Peptides · 2004 · 63 citations

Species Selectivity, Health Sciences, Functional Selectivity +8

Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits

James C. Hershey, Elizabeth Baskin, Halea A. Corcoran et al. · Heart and Vessels · 2003 · 39 citations

Developmental Biology, Angiogenesis, Cardiovascular Disease +10

Laser Doppler Imaging of Reactive Hyperemia Exposes Blood Flow Deficits in a Rat Model of Experimental Limb Ischemia

Halea A. Corcoran, Brad Smith, Parker D. Mathers et al. · Journal of Cardiovascular Pharmacology · 2009 · 15 citations

Hypertension, Rat Model, Cerebral Vascular Regulation +20

Potent benzimidazolone-based CGRP receptor antagonists

Cory R. Theberge, Rodney A. Bednar, Ian M. Bell et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 13 citations · Full text

Medicine, Mechanism Of Action, Pharmacological Agent +3